|
Charles, L G; Xie, Y C; Restifo, N P et al. (2000) Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development. World J Urol 18:136-42
|
|
Sanda, M G; Smith, D C; Charles, L G et al. (1999) Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer. Urology 53:260-6
|
|
Eng, M H; Charles, L G; Ross, B D et al. (1999) Early castration reduces prostatic carcinogenesis in transgenic mice. Urology 54:1112-9
|
|
Hwang, C; Sanda, M G (1999) Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. Curr Opin Mol Ther 1:471-9
|
|
Xie, Y C; Hwang, C; Overwijk, W et al. (1999) Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J Natl Cancer Inst 91:169-75
|
|
Hsu, C X; Ross, B D; Chrisp, C E et al. (1998) Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J Urol 160:1500-5
|
